Icon

CLARINEX D 24 HOUR (nda021605)- (5MG;240MG)

DESLORATADINE; PSEUDOEPHEDRINE SULFATE ORGANON
5MG;240MG
Yes No
2022-Sep-28 Expired
None None
None No
CLARINEX-D® 24 HOUR Extended Release Tablets is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis, including nasal congestion, in patients 12 years of age and older. CLARINEX-D® 24 HOUR Extended Release Tablets should be administered when the antihistaminic properties of desloratadine and the nasal decongestant properties of pseudoephedrine are desired.
1 0 0
Total Other Developers None
Drugs with Suitability No
5MG;240MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.